Evidence map›Paper›PMID 23997114›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2013

Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Parrisa Solaimani, Robert Damoiseaux, Oliver Hankinson

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Armc8 regulates the invasive ability of hepatocellular carcinoma through E-cadherin/catenin complex.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Parrisa Solaimani* Molecular Toxicology Interdepartmental Program, Department of Pathology and Laboratory Medicine, and the Jonsson Comprehensive Cancer Center and.
Robert Damoiseaux
Oliver Hankinson
California NanoSystems Institute · USUniversity of Colorado Cancer Center · USUniversity of Colorado Denver · US

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Training in Molecular ToxicologyT32ES015457 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALLARD, PATRICK, HANKINSON, OLIVER NMN · 2008 to 2025
$4.0M
CARCINOGEN ACTIVATION AND SCREENING IN VARIANT CELLSR01CA028868 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HANKINSON, OLIVER NMN · 1985 to 2010
$3.6M
Function and Regulation of Human Cytochrome P4502S1R01ES015384 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HANKINSON, OLIVER NMN · 2006 to 2010
$1.7M
NCI NIH HHS P30CA160442NCI NIH HHS R01CA28868NIAID NIH HHS P30AI28697NIEHS NIH HHS R01ES015384NIEHS NIH HHS T32 ES015457NIEHS NIH HHS T32ES015457
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AHR) has a plethora of physiological roles, and upon dysregulation, carcinogenesis can occur. One target gene of AHR encodes the xenobiotic and drug-metabolizing enzyme CYP1A1, which is inducible by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via the AHR. An siRNA library targeted against over 5600 gene candidates in the druggable genome was used to transfect mouse Hepa-1 cells, which were then treated with TCDD, and subsequently assayed for CYP1A1-dependent ethoxyresorufin-o-deethylase (EROD) activity. Following redundant siRNA activity (RSA) statistical analysis, we identified 93 hits that reduced EROD activity with a p value ≤ .005 and substantiated 39 of these as positive hits in a secondary screening using endoribonuclease-prepared siRNAs (esiRNAs). Twelve of the corresponding gene products were subsequently confirmed to be necessary for the induction of CYP1A1 messenger RNA by TCDD. None of the candidates were deficient in aryl hydrocarbon nuclear translocator expression. However 6 gene products including UBE2i, RAB40C, CRYGD, DCTN4, RBM5, and RAD50 are required for the expression of AHR as well as for induction of CYP1A1. We also found 2 gene products, ARMC8 and TCF20, to be required for the induction of CYP1A1, but our data are ambiguous as to whether they are required for the expression of AHR. In contrast, SIN3A, PDC, TMEM5, and CD9 are not required for AHR expression but are required for the induction of CYP1A1, implicating a direct role in Cyp1a1 transcription. Our methods, although applied to Cyp1a1, could be modified for identifying proteins that regulate other inducible genes.

Indexed as

High-Throughput Screening AssaysRNA InterferenceAnimalsBasic Helix-Loop-Helix ProteinsCell Line, TumorCytochrome P-450 CYP1A1Enzyme InductionEye ProteinsGenes, ReporterGenome-Wide Association StudyGTP-Binding Protein RegulatorsHepatocytesMiceOxazinesPhosphoproteinsPolychlorinated DibenzodioxinsAHR protein, humanBasic Helix-Loop-Helix ProteinsCd9 protein, mouseCytochrome P-450 CYP1A1ethoxyresorufinEye ProteinsGTP-Binding Protein RegulatorsOxazinesphosducinPhosphoproteinsPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonRepressor ProteinsRNA, MessengerSIN3A transcription factorSin3 Histone Deacetylase and Corepressor ComplexTetraspanin 29AHRCYP1A1esiRNA.high-throughput screeningRNAiTCDD

Identifiers

PMID23997114
PMCPMC3829574
OpenAlexW2148574603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.